Shanghai Kaibao Pharmaceutical (300039) — Capital Reinvestment Ratio
Shanghai Kaibao Pharmaceutical (300039) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥190.98 Million) in capital expenditures (CN¥3.37 Million). See how leveraged is Shanghai Kaibao Pharmaceutical's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Kaibao Pharmaceutical Capital Reinvestment Ratio (2006–2024)
This chart tracks Shanghai Kaibao Pharmaceutical's Capital Reinvestment Ratio across 19 annual periods. Check cash flow reinvestment rate of Shanghai Kaibao Pharmaceutical to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shanghai Kaibao Pharmaceutical (2006–2024)
Year-by-year Capital Reinvestment Ratio for Shanghai Kaibao Pharmaceutical from 2006 to 2024. For live market cap and broader valuation context, see Shanghai Kaibao Pharmaceutical market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.50x | CN¥278.95 Million | CN¥140.52 Million | ▲ +563.0% |
| 2023 | 0.08x | CN¥382.66 Million | CN¥29.08 Million | ▼ -9.5% |
| 2022 | 0.08x | CN¥376.42 Million | CN¥31.62 Million | ▼ -75.1% |
| 2021 | 0.34x | CN¥126.08 Million | CN¥42.55 Million | ▲ +506.8% |
| 2020 | 0.06x | CN¥250.65 Million | CN¥13.94 Million | ▲ +20.2% |
| 2019 | 0.05x | CN¥334.09 Million | CN¥15.46 Million | ▼ -53.4% |
| 2018 | 0.10x | CN¥262.36 Million | CN¥26.07 Million | ▼ -50.4% |
| 2017 | 0.20x | CN¥245.76 Million | CN¥49.24 Million | ▲ +133.4% |
| 2016 | 0.09x | CN¥314.88 Million | CN¥27.03 Million | ▼ -44.3% |
| 2015 | 0.15x | CN¥327.08 Million | CN¥50.40 Million | ▼ -36.7% |
| 2014 | 0.24x | CN¥282.38 Million | CN¥68.74 Million | ▼ -44.4% |
| 2013 | 0.44x | CN¥270.23 Million | CN¥118.28 Million | ▲ +104.0% |
| 2012 | 0.21x | CN¥243.32 Million | CN¥52.21 Million | ▼ -69.4% |
| 2011 | 0.70x | CN¥98.31 Million | CN¥68.85 Million | ▼ -72.8% |
| 2010 | 2.58x | CN¥19.79 Million | CN¥51.01 Million | ▲ +8.1% |
| 2009 | 2.38x | CN¥52.74 Million | CN¥125.70 Million | ▲ +294.9% |
| 2008 | 0.60x | CN¥18.70 Million | CN¥11.28 Million | ▲ +204.1% |
| 2007 | 0.20x | CN¥23.27 Million | CN¥4.62 Million | ▼ -66.7% |
| 2006 | 0.60x | CN¥19.70 Million | CN¥11.74 Million | — |